Opening Salomat

On October 30, 2026, a series of new manufacturing and logistics projects was presented in Dushanbe in the presence of Emomali Rahmon, President of the Republic of Tajikistan and Leader of the Nation, and Rustami Emomali, Chairman of the Majlisi Milli of the Majlisi Oli of the Republic of Tajikistan and Mayor of Dushanbe.Among the initiatives were new projects by Evar and Khonai Man, both part of KOINOTI NAV Group of Companies. These investments aim to expand domestic manufacturing, introduce advanced technologies, and create new employment opportunities.Construction was launched on a modern production and logistics complex for Evar LLC in the Arbobkhotun neighborhood of Dushanbe's Sino District. The project includes a food production center as well as facilities for processing and packaging fruits and vegetables. Once completed, the complex is expected to create 930 permanent jobs.A new manufacturing project by Khonai Man LLC was also presented. Equipped with modern production technology, the facility will have an annual capacity of 10,000 tables, 5,000 beds, 4,000 wardrobes, 4,000 chairs of various types, and 5,000 units of medical equipment. The project is expected to create another 60 permanent jobs.For KOINOTI NAV Group of Companies, the expansion of Evar and Khonai Man's manufacturing activities is part of a long-term approach to business growth, greater production efficiency, and the creation of new economic opportunities.These initiatives will contribute to strengthening Tajikistan's domestic industry, developing modern infrastructure, and creating additional employment opportunities across the country.

On October 30, 2026, the official inauguration of Rhazes Pharma, a modern pharmaceutical manufacturing facility within the KOINOTI NAV Group of Companies' portfolio, took place in Dushanbe.The opening ceremony was attended by Emomali Rahmon, President of the Republic of Tajikistan and Leader of the Nation, and Rustami Emomali, Chairman of the Majlisi Milli of the Majlisi Oli of the Republic of Tajikistan and Mayor of Dushanbe.Located in the Arbobkhotun neighborhood of Dushanbe's Sino District, the new facility marks an important milestone in the development of Tajikistan's domestic pharmaceutical industry, the expansion of national manufacturing capabilities, and the strengthening of pharmaceutical security.Rhazes Pharma is a joint Tajik-Indian enterprise established in 2022. The project was launched in May 2024 under an investment agreement between the Government of the Republic of Tajikistan and Rhazes Pharma.The first phase of the project includes four operational production lines manufacturing 100 types of pharmaceutical products. The facility has an annual production capacity of 1.4 billion tablets, 300 million capsules, 21 million units of liquid medicines for external use, and 13 million units of ointments, creams, and gels. The product portfolio is expected to expand to 250 types in the future.The plant is equipped with advanced manufacturing technology sourced from the United States, Italy, Germany, and Japan. Its operations incorporate automated production processes, digital management systems, and a specialized quality control laboratory. Manufacturing is organized in accordance with Good Manufacturing Practice (GMP) principles, ensuring quality control of raw materials and finished products throughout the production process.Once the first phase reaches full production capacity, the facility is expected to provide more than 300 permanent jobs, creating new employment opportunities and supporting the professional development of local specialists.The second phase of the project will involve the construction of an additional manufacturing facility covering more than 10,000 square meters, with planned investments exceeding TJS 150 million. This expansion is expected to create another 150 jobs and introduce the production of 100 types of liquid pharmaceutical products in ampoules and large plastic containers, with a combined annual capacity of up to 125 million units.For KOINOTI NAV Group of Companies, the opening of Rhazes Pharma represents a significant milestone in expanding its pharmaceutical business and advancing long-term investment initiatives.The launch of this modern manufacturing facility creates new opportunities to expand the range of locally produced medicines, reduce reliance on imports, develop professional expertise, and strengthen Tajikistan's export potential.Projects of this scale reflect the Holding's commitment to investing in strategically important sectors, introducing advanced technologies, and creating sustainable opportunities for the country's long-term development.

MEDSI Group, Russia’s largest federal network of private clinics, has entered the healthcare market of Tajikistan with the opening of its first international medical center. The new multidisciplinary clinic is located at 79 Shirinshoh Shotemur Street in Dushanbe.The medical center covers more than 2,500 sq. m and operates as a full-cycle clinic, designed to serve up to 600 patients per day — over 216,000 patients annually. The center brings together five key departments: therapy, pediatrics, surgery, dentistry, and diagnostics. In total, the clinic provides care across 35 medical specialties and welcomes both adults and children.More than 50 doctors work at the center, including MEDSI experts from Russia and Tajik specialists with international experience. The clinic is equipped with 23 consultation rooms, two operating rooms, a 24/7 surgical inpatient unit, and an intensive care unit.The new medical center is set to become an important driver for healthcare development in the region. It provides access to advanced medical care of international standards and helps reduce the need for patients to travel abroad for treatment. The clinic also addresses several high-demand medical areas in the region, including allergy and immunology, endoscopy, coloproctology, traumatology and orthopedics, rheumatology, nephrology, efferent therapy, and pediatric dentistry.The clinic is equipped with modern medical technology, including a digital dermatoscope based on biophotonics, the GENORAY mammography system, the SonoScape HD-550 video endoscopy system, the Dixion ST-E600 ENT workstation, and the AP-01 membrane plasmapheresis device. This allows doctors to perform highly accurate diagnostics and minimally invasive procedures.“The opening of the clinic in Dushanbe is a milestone that confirms our readiness for global leadership. We are not simply entering a new country — we are bringing advanced technologies and our unique culture of patient care. Tajikistan became the starting point of our international journey because we see strong demand for high-quality medical services here, as well as trust in Russian healthcare standards. This strategic step is of great importance both for strengthening the MEDSI brand and for the development of Russian private medicine as a whole. We see it as the beginning of further international expansion. We believe there is significant potential ahead and will continue opening new horizons, sharing our expertise, and helping shape new healthcare standards internationally,” said Andrey Gennadievich Sokolov, President of MEDSI Group.The clinic follows unified MEDSI clinical protocols and strict quality control standards. Patients can also be routed across the wider MEDSI network through telemedicine consultations with Russian experts, remote medical boards, and referrals to specialized MEDSI centers as part of medical tourism programs with full patient support.The clinic’s team applies modern clinical protocols and evidence-based treatment methods. MEDSI’s competency-based approach combines years of clinical experience, proprietary medical practices, advanced scientific achievements, innovative technologies, and high-performance medical equipment.The project was developed in line with the concept of an accessible environment. The clinic includes ramps, automatic doors, elevators, handrails, and adapted restrooms for patients with limited mobility and parents with children. Trained staff are available to provide support and assistance.The opening of the clinic also has strong social value. It will become a platform for the professional development of local medical specialists, help reduce outbound medical travel, and strengthen public trust in the private healthcare sector in Tajikistan.“We are pleased to launch the first MEDSI center in Tajikistan and see this as an important step toward supporting people’s health and wellbeing. Our goal is to create not just a clinic, but a space where top specialists, modern equipment, and high-quality service come together so that every patient feels confident and supported. We believe this project will become an example of how private medicine can serve as a strong driver for regional healthcare development,” said Muhammad Khurshedovich Mirzoev, Director of MEDSI Tajikistan.The clinic operates in the upper mid-market segment. Patients can pay in cash or by bank transfer. Voluntary health insurance programs are expected to be introduced in the near future. The clinic is open daily from 8:00 a.m. to 9:00 p.m.